$CCRD
CoreCard Corp

2020 Q1 Form 10-Q Financial Statement

#000143774920009353 Filed on May 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1 2018 Q4
Revenue $7.893M $6.966M $6.050M
YoY Change 13.31% 71.66% 137.25%
Cost Of Revenue $3.506M $2.534M $2.420M
YoY Change 38.36% 45.38% 69.23%
Gross Profit $4.387M $4.432M $3.640M
YoY Change -1.02% 91.45% 227.93%
Gross Profit Margin 55.58% 63.62% 60.17%
Selling, General & Admin $1.090M $632.0K $480.0K
YoY Change 72.47% 16.82% 17.07%
% of Gross Profit 24.85% 14.26% 13.19%
Research & Development $918.0K $1.195M $890.0K
YoY Change -23.18% 25.39% -36.88%
% of Gross Profit 20.93% 26.96% 24.45%
Depreciation & Amortization $300.0K $180.0K $180.0K
YoY Change 66.67% 38.46% 100.0%
% of Gross Profit 6.84% 4.06% 4.95%
Operating Expenses $2.008M $1.827M $1.370M
YoY Change 9.91% 22.29% 1612.5%
Operating Profit $2.379M $2.605M $2.270M
YoY Change -8.68% 217.3% 120.39%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $136.0K $102.0K $340.0K
YoY Change 33.33% 41.67% -120.24%
Pretax Income $1.465M $2.731M $2.250M
YoY Change -46.36% 205.82% -451.56%
Income Tax $418.0K $659.0K -$180.0K
% Of Pretax Income 28.53% 24.13% -8.0%
Net Earnings $1.047M $2.072M $2.430M
YoY Change -49.47% 132.03% -473.85%
Net Earnings / Revenue 13.26% 29.74% 40.17%
Basic Earnings Per Share $0.12 $0.23
Diluted Earnings Per Share $0.12 $0.23 $0.27
COMMON SHARES
Basic Shares Outstanding 8.925M 8.841M
Diluted Shares Outstanding 9.022M 8.990M

Balance Sheet

Concept 2020 Q1 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.54M $22.45M $19.27M
YoY Change 36.04% 111.79% 33.23%
Cash & Equivalents $30.54M $22.07M $18.92M
Short-Term Investments $380.0K $349.0K
Other Short-Term Assets $979.0K $1.092M $1.202M
YoY Change -10.35% -78.36% -49.35%
Inventory
Prepaid Expenses
Receivables $8.083M $3.689M $3.731M
Other Receivables $0.00 $0.00 $580.0K
Total Short-Term Assets $39.60M $27.23M $24.78M
YoY Change 45.42% 44.54% 37.23%
LONG-TERM ASSETS
Property, Plant & Equipment $2.414M $1.445M $1.513M
YoY Change 67.06% 11.07% 19.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $760.0K $760.0K
YoY Change -100.0% -25.49% -26.92%
Other Assets $3.428M $1.637M $504.0K
YoY Change 109.41% 690.82% 191.33%
Total Long-Term Assets $10.70M $6.703M $4.522M
YoY Change 59.63% 67.2% 21.56%
TOTAL ASSETS
Total Short-Term Assets $39.60M $27.23M $24.78M
Total Long-Term Assets $10.70M $6.703M $4.522M
Total Assets $50.30M $33.93M $29.30M
YoY Change 48.23% 48.51% 34.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $372.0K $272.0K $272.0K
YoY Change 36.76% 110.85% -15.26%
Accrued Expenses $293.0K $127.0K $71.00K
YoY Change 130.71% 20.95% -27.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.411M $5.114M $3.272M
YoY Change 84.02% 112.02% 43.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.250M $740.0K $110.0K
YoY Change 204.05% 722.22%
Total Long-Term Liabilities $2.522M $744.0K $111.0K
YoY Change 238.98% 726.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.411M $5.114M $3.272M
Total Long-Term Liabilities $2.522M $744.0K $111.0K
Total Liabilities $11.93M $5.858M $3.383M
YoY Change 103.7% 133.39% 48.7%
SHAREHOLDERS EQUITY
Retained Earnings $22.89M $12.95M $10.88M
YoY Change 76.81% 134.38% 134.83%
Common Stock $15.60M $15.22M $15.14M
YoY Change 2.49% 1.63% 1.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.37M $28.08M $25.92M
YoY Change
Total Liabilities & Shareholders Equity $50.30M $33.93M $29.30M
YoY Change 48.23% 48.51% 34.55%

Cashflow Statement

Concept 2020 Q1 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income $1.047M $2.072M $2.430M
YoY Change -49.47% 132.03% -473.85%
Depreciation, Depletion And Amortization $300.0K $180.0K $180.0K
YoY Change 66.67% 38.46% 100.0%
Cash From Operating Activities $5.693M $3.706M $1.670M
YoY Change 53.62% -216.28% -214.38%
INVESTING ACTIVITIES
Capital Expenditures $539.0K $112.0K $210.0K
YoY Change 381.25% -34.12% -54.35%
Acquisitions
YoY Change
Other Investing Activities -$1.000M -$500.0K $0.00
YoY Change 100.0% 2.04% -100.0%
Cash From Investing Activities -$1.539M -$612.0K -$200.0K
YoY Change 151.47% -6.56% -79.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 59.00K 80.00K
YoY Change
NET CHANGE
Cash From Operating Activities 5.693M 3.706M 1.670M
Cash From Investing Activities -1.539M -612.0K -200.0K
Cash From Financing Activities 59.00K 80.00K
Net Change In Cash 4.123M 3.153M 1.550M
YoY Change 30.76% -182.07% -164.05%
FREE CASH FLOW
Cash From Operating Activities $5.693M $3.706M $1.670M
Capital Expenditures $539.0K $112.0K $210.0K
Free Cash Flow $5.154M $3.594M $1.460M
YoY Change 43.41% -207.06% -176.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 ins Number Of Stockbased Compensation Plans In Effect
NumberOfStockbasedCompensationPlansInEffect
3
CY2020Q1 ins Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
1000000
CY2019Q1 ins Payments For Notes And Interest Receivable
PaymentsForNotesAndInterestReceivable
500000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
372000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
403000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8083000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8759000
CY2020Q1 ins Notes And Interest Receivable Current
NotesAndInterestReceivableCurrent
2568000
CY2019Q4 ins Notes And Interest Receivable Current
NotesAndInterestReceivableCurrent
1795000
CY2020Q1 ins Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
3422000
CY2019Q1 ins Increase Decrease In Deferred Revenue Current
IncreaseDecreaseInDeferredRevenueCurrent
124000
CY2020Q1 ins Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
-8000
CY2019Q1 ins Increase Decrease In Deferred Revenue Noncurrent
IncreaseDecreaseInDeferredRevenueNoncurrent
-37000
CY2020Q1 ins Noncash Interest Income
NoncashInterestIncome
32000
CY2019Q1 ins Noncash Interest Income
NoncashInterestIncome
30000
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1440000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1100000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
293000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
153000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-125000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-94000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15512000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
15450000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
62000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25000
CY2020Q1 us-gaap Assets
Assets
50300000
CY2019Q4 us-gaap Assets
Assets
44240000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
39600000
CY2019Q1 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
275000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
275000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
36079000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30538000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26415000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18919000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22071000
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4123000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3152000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8924988
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8924988
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8924988
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8924988
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
89000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
89000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1016000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2071000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
3506000
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
2534000
CY2020Q1 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
1009000
CY2020Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4111000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
689000
CY2020Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
15000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
23000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
302000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
180000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-31000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1412000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2503000
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
353000
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
0
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1058000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
594000
CY2019Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
140000
CY2020Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
74000
CY2019Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-110000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1465000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2731000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-41000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
418000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
659000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-31000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-676000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-42000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
140000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
56000
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1091000
CY2020Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
236000
CY2019Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1061000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
6000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
37000
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
-1050000
CY2019Q1 us-gaap Investment Income Net
InvestmentIncomeNet
24000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50300000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44240000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9411000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6193000
CY2020Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2522000
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
758000
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2020Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2020Q1 us-gaap Long Term Investments
LongTermInvestments
2290000
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
3081000
CY2020Q1 us-gaap Marketing Expense
MarketingExpense
32000
CY2019Q1 us-gaap Marketing Expense
MarketingExpense
38000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1539000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-612000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5693000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3706000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1047000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
2072000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2379000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2605000
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
142000
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
130000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2232000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
460000
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y36D
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
979000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
905000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3428000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1108000
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-31000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-31000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
CY2020Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1783000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1345000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
136000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
102000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
539000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
112000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
59000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
1047000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
2072000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2414000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2177000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
918000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1195000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22891000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
21844000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7893000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6966000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
62000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3209875
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
126500
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.94
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2825115
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
94500
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
4.09
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y219D
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P2Y328D
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
59000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
25921000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
28076000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
37289000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
38367000
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9021754
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8990438
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8924988
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8841321

Files In Submission

Name View Source Status
0001437749-20-009353-index-headers.html Edgar Link pending
0001437749-20-009353-index.html Edgar Link pending
0001437749-20-009353.txt Edgar Link pending
0001437749-20-009353-xbrl.zip Edgar Link pending
ex_182879.htm Edgar Link pending
ex_182880.htm Edgar Link pending
ex_182881.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ins-20200331.xml Edgar Link completed
ins-20200331.xsd Edgar Link pending
ins-20200331_cal.xml Edgar Link unprocessable
ins-20200331_def.xml Edgar Link unprocessable
ins-20200331_lab.xml Edgar Link unprocessable
ins-20200331_pre.xml Edgar Link unprocessable
ins20200331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending